Rockwell Medical

RMTI78

Penny Stock

$2.31arrow_drop_up2.66%$0.06

Penny Stock

RMTI78

$2.31

arrow_drop_up2.66%$0.06

Penny Stock

Performance History

Key Stats
Open	$2.30
Prev. Close	$2.25
EPS	-0.04
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$74.65M
PE Ratio	-

	LOW	HIGH
Day Range	2.23	2.39
52 Week Range	1.16	5.08

Ratios

Revenue	-





EPS	-0.04

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Rockwell Medical (RMTI)

Rockwell Medical Inc. (RMTI) is a pharmaceutical company that specializes in the development and commercialization of innovative products for the treatment of kidney disease. The company focuses on improving patient outcomes and reducing healthcare costs through its proprietary products and therapies. With a strong commitment to research and development, Rockwell Medical continuously strives to address the unmet needs of patients suffering from chronic kidney disease.

Founded in 1995, Rockwell Medical has grown into a leading player in the kidney disease market. The company's flagship product, Triferic, is an iron replacement therapy that is administered directly to the patient during dialysis treatment. Triferic helps to restore and maintain hemoglobin levels in dialysis patients, reducing the reliance on erythropoiesis-stimulating agents (ESAs) and improving overall iron management. This innovative therapy has the potential to significantly impact the lives of millions of patients worldwide.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Dr. Mark Strobeck Ph.D.
Headquarters: Wixom
Employees: 253
Exchange: NASDAQ

Keep an eye on Rockwell Medical

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Rockwell Medical 's (RMTI) price per share?

The current price per share for Rockwell Medical (RMTI) is $2.31. The stock has seen a price change of $0.06 recently, indicating a 2.67% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Rockwell Medical (RMTI)?

For Rockwell Medical (RMTI), the 52-week high is $5.08, which is 120% from the current price. The 52-week low is $1.16, the current price is 99.14% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Rockwell Medical (RMTI) a growth stock?

Rockwell Medical (RMTI) has shown an average price growth of -3.36% over the past three years. It has received a score of 55 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Rockwell Medical as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Rockwell Medical (RMTI) stock price performance year to date (YTD)?

As of the latest data, Rockwell Medical (RMTI) has a year-to-date price change of 24.19%. Over the past month, the stock has experienced a price change of -36.01%. Over the last three months, the change has been -24.51%. Over the past six months, the figure is 27.62%. Looking at a longer horizon, the five-year price change stands at -90.37%.

help

Is Rockwell Medical (RMTI) a profitable company?

Rockwell Medical (RMTI) has a net income of -$8.44M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 10.41% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 1.99% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 14.84%, providing insight into the company's sales performance and growth. The gross profit is $8.7M. Operating income is noted at -$6.67M. Furthermore, the EBITDA is -$885K.

help

What is the market capitalization of Rockwell Medical (RMTI)?

Rockwell Medical (RMTI) has a market capitalization of $74.66M. The average daily trading volume is 2.31, indicating the stock's liquidity and investor engagement.